Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
Erythropoietin (EPO) has been shown to be neurotrophic and neuroprotective in several animal
models and some clinical studies. Our hypothesis is that EPO could improve long-term
neurological outcomes in very preterm infants with intraventricular hemorrhage (IVH). The aim
of this study is to evaluate the long-term neuroprotective effect of repeated low-dose EPO
(500 U/kg) in very preterm infants with IVH.
Phase:
Phase 2
Details
Lead Sponsor:
Zhengzhou University
Collaborators:
Göteborg University Zhengzhou Children's Hospital, China